Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

Use of montelukast not associated with risk of neuropsychiatric adverse events among children suggests a new study published in the JAMA.Spontaneous reports have indicated that ...